인쇄하기
취소

MFDS takes action to suspend Hanmi Pharm’s clinical trial for 3 months

Published: 2016-12-21 15:00:03
Updated: 2016-12-21 15:00:03

The Ministry of Food and Drug Safety(MFDS) decided to take an administrative action to suspend a Hanmi Pharm’s clinical trial.

Minister Mun-gi Sohn of Food and Drug Safety participated the National Assembly Health and Welfare Committee’s general meeting on the 19th, and made a report it has a plan to take an administrative action to suspend the clinical trial for 3 months for the company’s adv...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.